Paper14701780
Phase I study of the humanized antiepidermal growth factor receptor monoclonal antibody EMD72000 in patients with advanced solid tumors that express the epidermal growth factor receptor.
Vanhoefer U and 12 others. J Clin Oncol, 2004. Cited by 213 papers, by iCite.
Cite this record
ConductScience Library. Phase I study of the humanized antiepidermal growth factor receptor monoclonal antibody EMD72000 in patients with advanced solid tumors that express the epidermal growth factor receptor. Papers, record 14701780. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/14701780
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Phase I study of the humanized antiepidermal growth factor receptor monoclonal antibody EMD72000 in patients with advanced solid tumors that express the epidermal growth factor receptor.
- PubMed
- Publication types
- Clinical Trial, Clinical Trial, Phase I, Journal Article, Research Support, Non-U.S. Gov't
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Monoclonal | Major topic |
| Antineoplastic Agents | Major topic |
| ErbB Receptors | Major topic |
| Neoplasms | Major topic |
| Adult | |
| Aged | |
| Antibodies, Monoclonal, Humanized | |
| Cetuximab | |
| Female | |
| Fever | |
| Headache | |
| Humans | |
| Male | |
| Maximum Tolerated Dose | |
| Middle Aged | |
| Treatment Outcome |
Source PubMed
Cited by58
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 213 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 32533228 | Radiochemotherapy with or without cetuximab for unresectable esophageal cancer: final results of a randomized phase 2 trial (LEOPARD-2). | Strahlenther Onkol | 2020 | https://conductscience.org/library/papers/32533228 | PubMed |
| 30805388 | Monoclonal Antibody Production Against Vimentin by Whole Cell Immunization in a Mouse Model. | Iran J Biotechnol | 2018 | https://conductscience.org/library/papers/30805388 | PubMed |
| 29438365 | Strategies for clinical development of monoclonal antibodies beyond first-in-human trials: tested doses and rationale for dose selection. | Br J Cancer | 2018 | https://conductscience.org/library/papers/29438365 | PubMed |
| 27494775 | Therapeutic targets and new directions for antibodies developed for ovarian cancer. | MAbs | 2016 | https://conductscience.org/library/papers/27494775 | PubMed |
| 26267324 | Molecular classification of gastric cancer: Towards a pathway-driven targeted therapy. | Oncotarget | 2015 | https://conductscience.org/library/papers/26267324 | PubMed |
| 26019442 | Gastric cancer and the epoch of immunotherapy approaches. | World J Gastroenterol | 2015 | https://conductscience.org/library/papers/26019442 | PubMed |
| 25806192 | EGFR-directed monoclonal antibodies in non-small cell lung cancer: how to predict efficacy? | Transl Lung Cancer Res | 2012 | https://conductscience.org/library/papers/25806192 | PubMed |
| 25806155 | Cetuximab in non-small-cell lung cancer. | Transl Lung Cancer Res | 2012 | https://conductscience.org/library/papers/25806155 | PubMed |
| 25733832 | Toward a magic or imaginary bullet? Ligands for drug targeting to cancer cells: principles, hopes, and challenges. | Int J Nanomedicine | 2015 | https://conductscience.org/library/papers/25733832 | PubMed |
| 25501029 | REAL-Select: full-length antibody display and library screening by surface capture on yeast cells. | PLoS One | 2014 | https://conductscience.org/library/papers/25501029 | PubMed |
| 25323095 | Immunohistochemical expression of receptor tyrosine kinase PDGFR-α, c-Met, and EGFR in skull base chordoma. | Neurosurg Rev | 2015 | https://conductscience.org/library/papers/25323095 | PubMed |
| 24929808 | Prognostic significance of immunohistochemical expression of VEGFR2 and iNOS in spinal chordoma. | Eur Spine J | 2014 | https://conductscience.org/library/papers/24929808 | PubMed |
| 23314653 | Pre-emptive skin toxicity treatment for anti-EGFR drugs: evaluation of efficacy of skin moisturizers and lymecycline. A phase II study. | Support Care Cancer | 2013 | https://conductscience.org/library/papers/23314653 | PubMed |
| 23300028 | EGFR-directed monoclonal antibodies in non-small cell lung cancer. | Target Oncol | 2013 | https://conductscience.org/library/papers/23300028 | PubMed |
| 23150825 | The use of epidermal growth factor receptor monoclonal antibodies in squamous cell carcinoma of the head and neck. | Chemother Res Pract | 2012 | https://conductscience.org/library/papers/23150825 | PubMed |
| 22832803 | A phase I pharmacokinetic study of matuzumab in combination with paclitaxel in patients with EGFR-expressing advanced non-small cell lung cancer. | Invest New Drugs | 2013 | https://conductscience.org/library/papers/22832803 | PubMed |
| 22763610 | Phase I study of matuzumab in combination with 5-fluorouracil, leucovorin and cisplatin (PLF) in patients with advanced gastric and esophagogastric adenocarcinomas. | Invest New Drugs | 2013 | https://conductscience.org/library/papers/22763610 | PubMed |
| 22754591 | Combining chemotherapy with epidermal growth factor receptor inhibition in advanced non-small cell lung cancer. | Ther Adv Med Oncol | 2012 | https://conductscience.org/library/papers/22754591 | PubMed |
| 22640435 | Cutting edge in medical management of cutaneous oncology. | Semin Cutan Med Surg | 2012 | https://conductscience.org/library/papers/22640435 | PubMed |
| 22253528 | Novel immunotherapeutic strategies of gastric cancer treatment. | J Biomed Biotechnol | 2011 | https://conductscience.org/library/papers/22253528 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| EGFR | 1956 | PubTator's text mining | https://conductscience.org/library/genes/1956 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/14701780
GET https://conductscience.org/api/papers/v1/14701780/cited_by?page=2